TTM Q3 net sales $572.6M; GAAP loss $0.36/sh on $44.1M goodwill impairment; non-GAAP EPS $0.43 beats guidance

TTM TECHNOLOGIES INC

2023-Q3 EPS reported -$0.35 revenue$1,663,528,000

Net sales $572.6M, down 14.7% YoY from $671.1M; GAAP net loss $37.1M ($0.36 loss per share).
Non-GAAP net income $44.9M ($0.43 per share) vs guidance $0.34-$0.40, beat on North America and data center strength.
GAAP results include $44.1M goodwill impairment in RF&S Components segment.
Q4 guidance: revenue $550-590M, non-GAAP EPS $0.34-0.40 per diluted share.
Repurchased 1M shares for $14.6M at avg $14.33; cash from operations $58.9M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

TTM TECHNOLOGIES INC reported third quarter of fiscal year 2023, which ended on October 2, 2023 results: revenue $572.6 million, net income GAAP net loss of $37.1 million, or ($0.36) per diluted share. Guidance initiated.

Period: third quarter of fiscal year 2023, which ended on October 2, 2023
Revenue: $572.6 million
Net income: GAAP net loss of $37.1 million, or ($0.36) per diluted share
Guidance: initiated
Result: reported results

Exact text from the filing

and printed circuit boards (“PCB”), today reported results for the third quarter fiscal 2023, which ended on October 2, 2023. Third Quarter 2023 Highlights • Net sales were $572.6 million • GAAP net loss of $37.1 million, or ($0.36) per diluted share, inclusive of a goodwill impairment charge of $44.1 million • Non-GAAP net income was $44.9 million, or $0.43 per

View on SEC.gov

3 earnings releases filed in the last 30 days. Browse all earnings releases →

TTM TECHNOLOGIES INC filing history →

Source: SEC EDGAR

accession 0001193125-23-267755

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.